ConductScience.org, home

Gene · 30849

NIH grants979

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitlePIK3R4 papersNewest fiscal year
R01AI109023Defining P. falciparum resistance to artemisinin-based combination therapies12025
R01AI120607Parasite autophagy as a key survival mechanism for the AIDS-associated pathogen Toxoplasma gondii12025
R01AI121244Redefining the role of autophagy in bacterial disease12025
R01AI155545Anti-inflammatory functions for non-transcriptional IRF312025
R01AI165521Novel antiviral mechanisms of the interferon system12025
R01AI177555A comprehensive investigation of Pseudomonas quorum sensing regulatory relationships and the consequences on quorum sensing inhibitors in complex communities12025
R01AR043369MITF from control of pigmentation to melanoma risk12025
R01AR062173The IL-23/IL-17 Axis in Inflammatory Arthritis12025
R01CA072038Replication Stress and DNA Damage Response Drives ESR1 Mutant Metastasis12025
R01CA096512Cell model for KSHV infection and genetic manipulation12025
R01CA102184Functional Analysis of p53 Polymorphic Variants12025
R01CA251726Targeting the autophagy-lysosome system to block pancreatic cancer12025
R01CA266522Characterizing and targeting PRMT5 in autophagy for cancer treatment12025
R01CA273586Roles of Glial Autophagy in Breast Cancer Brain Metastasis12025
R01CA285446Elucidating a novel WNT4 regulatory axis as a driver of gynecologic cancer health disparities12025
R01DA012864Mechanisms and Cellular Function of Opioid Receptor Endocytosis12025
R01DA014204Regulation of Dopamine Transporter by Trafficking12025
R01DE016572Ceramide Signaling in the Regulation of Head & Neck Cancer Cell Death and Therapy12025
R01DE017102TRPC1, Calcium, and Saliva Secretion12025
R01DE026644Targeting Signaling Vulnerabilities for Oral Cancer Prevention12025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/30849/grants?page=6